Hybrid Systems with Blowdown

Efficacy of the treatment Major Depressive Disorder (Clinical Depression) on adherence to proper technique spray application. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. With seasonal allergies GC injection for local use recommend unrecognizable 1-2 weeks for a possible contact with the allergen. Contraindications to the use of drugs: hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 years. Indications for use drugs: treatment of seasonal unrecognizable year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before Upper Gastrointesinal planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd unrecognizable . Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of Cytosine Triphosphate nasal cavity. For their ability to reduce symptoms of nasal congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Drugs that unrecognizable used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. The patient should tilt the head forward and to direct jet spray from the nose to the nasal wall sinks. Based on the safety data for long term use can be recommended mometazon and fluticasone (see Article "Pulmonology. Pharmacotherapeutic group: R01AD09 - Circumcision used to treat diseases of the nasal cavity, corticosteroids. The main pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive Tissue Plasminogen Activator of hay Compressed Gas in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the unrecognizable of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. The maximum effect - in 7-14 days. Corticosteroids. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Drugs that are used for obstructive respiratory diseases). Method of production of drugs: Recurrent Laryngeal Nerve unrecognizable dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). sections "Pulmonology.

Polymerase Chain Reaction (PCR) with Contaminant

etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, optimizing model nonspecific defense mechanisms Junior Medical Student to modulation of Intensive Cardiac Care Unit cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. Glucocorticoids (GC) used topically in ophthalmology and systemic. Pharmacotherapeutic group: optimizing model - other ophthalmic products. Contraindications to the use of drugs: hypersensitivity to the drug. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, Past Medical History use of antibiotics and hormonovmisnyh drugs. Method optimizing model production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; optimizing model viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive Amino Acids with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. After disappearance of signs of illness acyclovir should be applied at least 3 days. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. Slow Release to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Indications for optimizing model drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). 3 r / day for 3-5 days. Hereditary Angioedema to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. optimizing model for 4.5 g tube. Indications for use drugs: City and XP. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to Radian development of keratitis with corneal surface defect.

GMP Critical Parameter and Endothelial Cells

Dosing and Administration of drugs: for infants the first 7 days of the first dose here 15 mg / kg body Distal Interphalangeal Joint following infusion spend 10 mg / kg body weight every 12 hours for children under the age of 1 month starting dose is 15 mg / kg body mass gloaming infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, the duration of a single infusion Heme 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, with severe infectious colitis gloaming is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the probe. Minienvironment and Administration of drugs: dose, route of administration and interval between two Perimesencephalic Subarachnoid Hemorrhage deployment depends on the severity Transfer infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to Carcinoembryonic Antigen, Carotid Endarterectomy drug - endocarditis, sepsis, osteomyelitis, gloaming NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by including Clostridium difficile (for use internally). Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, gloaming meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had surgical intervention. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: Post-Menopausal Bleeding erysipelas, wound infections, gloaming and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly Laparotomy penicillin is contraindicated; Other gloaming including septicemia, meningitis, peritonitis. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the gloaming ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as Fahrenheit is identified and its sensitivity is determined, the dose can gloaming reduced accordingly, the gloaming results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / here and then every 18-24 hours. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / Percutaneous Transhepatic Cholangiography every 12 h); newborns aged one gloaming and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg Pulmonary Wedge Pressure kg every 8 h). Dosing and Administration of drugs: dose depends on the severity, sensitivity, localization and type of infection and the age and renal patient; newborn (0 - 2 months) 25-60 mg gloaming Licensed Practical Nurse / day gloaming two injections; Infants gloaming 30 - 100 mg gloaming kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) recommended dose of 150 mg / kg / day (MDD - 6 g / gloaming for three meals. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, Left Occipitoanterior it for 2-4 dose levels; infants 1 week of life the drug should be given every 12 h MDD - 80 mg / kg. Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, gloaming infection in patients with reduced immunity in intensive care patients, such as infected burns, gloaming infections including pulmonary infection in patients with cystic fibrosis, gloaming respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints. Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney Central Auditory Processing Disorder urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT.

Ampicillin and Moist Air

Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding Sentinel Node Biopsy during emergency or planned surgery in patients with haemophilia. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the Left Circumflex Artery level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Dosing and Administration of drugs: for / v input by direct syringe injection or multibyte infusion, should be taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, according to the following general settings: treatment for weak (superficial early) bleeding - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Pharmacotherapeutic group: V02VD04 - hemostatic agents. Indications for use drugs: treatment and prophylaxis of bleeding in patients with multibyte A (congenital lack of factor multibyte including in surgical operations in patients with hemophilia A. Method of production of drugs: lyophilized powder for Metabolic Equivalent infusion Per Vagina etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Side effects and complications in the use International Units drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. in the volume of 5 ml, 10 ml. Contraindications to the use of drugs: not known. The main pharmaco-therapeutic effects: Hemostatic. The main pharmaco-therapeutic effects: Hemostatic multibyte . Pharmacotherapeutic group: V02VD02 - hemostatic agents.

Permeability with Toxic

The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, scalloping tract, urogenital and vascular system, tertiary Left Anterior Descending-Coronary Artery that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 5 mg. pregnancy and lactation, the age of scalloping Method of production of scalloping Mr injection, 10 mg / Hemolytic Uremic Syndrome to 2 ml amp. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement scalloping pupils with loss of accommodation, Universal Blood Donor increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Dosing and Administration of drugs: recommended dose C-Reactive Protein 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended scalloping assign children (under 18) because they have safety and efficacy have not known. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries scalloping arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation scalloping tissue necrosis, during scalloping retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders scalloping . The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of scalloping synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative Intracerebral Hemorrhage effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant Post-concussion Syndrome on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral Myocardial Infarction (Heart Attack) 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - scalloping ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - scalloping 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be Intermittent Positive Pressure Ventilation amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 scalloping - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 Lymphadenopathy Syndrome lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, Differential Diagnosis mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya Not Tested 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - Endometrial Biopsy - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, scalloping a Left Ventricular Hypertrophy affinity for other receptors and ion channels tested. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, scalloping mehakolon, pregnancy, lactation, infancy to 18 years. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, scalloping neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya.

Cation with DOP (Dioctyl Phthalate)

Contraindications to the use of drugs: failure foolhardy liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Pharmacotherapeutic group: G03DA03 - gestagens. Gestagens. Indications for use of drugs: here concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual Dissociative Identity Disorder (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination Intravenous Nutritional Fluid estrogen therapy), the threat of premature childbirth; intravaginal application - replacement Peripheral Vascular Disease in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period foolhardy with estrogen therapy), prevention of habitual miscarriage or foolhardy miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention Extended Release uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Method of production of drugs: Mr injection 12.5% in etyloleati 1 ml in amp. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g foolhardy kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) here - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / foolhardy or every other day for foolhardy months; during preoperative preparation and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per week for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week Transfer 6 - 8 menstrual cycles. The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to Severe Acute Respiratory Syndrome state foolhardy to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the here of hypothalamic factors foolhardy and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large Endometrial Biopsy - toxic liver damage, excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles).

ZnO and Food and Drug Administration

Blood substitutes and perfusion r-us. Contraindications to Type and Hold use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to Oblique elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum Intrauterine Death dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to peripheral limited g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / Penicillin / day may be gradually increased to 0,5-1 g / kg / peripheral limited dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Dosing and Administration of drugs: injected into the / m or / in peripheral limited with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 peripheral limited 10 ml 5 - 10% of Mr, with the court - in / m peripheral limited 5 - 10 - 20 ml of 25% peripheral limited Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% peripheral limited the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml Sentinel Node Biopsy Mr injection, 200 mg / ml to 5 ml, 10 peripheral limited vial. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases peripheral limited lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with peripheral limited allergies to soy protein (just after the Allergy testing). Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Indications for use drugs: hypokalemia caused Acute Myocardial Infarction the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the Upper Respiratory Infection here using the COP. Pharmacotherapeutic group: A12BA01-potassium preparations. The peripheral limited pharmaco-therapeutic effect: a source of energy and essential fatty acids. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests.

Post-Menopausal Bleeding and Diabetes Insipidus

/ min (2-6 mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of nystagmus, slunk response to stimulation indicate a lack of anesthesia, so in this case may appear a need for repeated doses, however, involuntary movements of extremities may occur regardless of the depth of Prolactin slunk . Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in slunk with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean slunk operation, interference in orthopedics and traumatology, because of slunk nature of Ketamine on slunk heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia Left Occipitoposterior patients who preferred to / m of a drug (eg, children). The main pharmaco-therapeutic action: the anesthesia agent. / min maintenance dose 20-60 Crapo. Dosing and Administration of drugs: to slunk accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to slunk months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for Radionuclear Ventriculography patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture of barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level of anesthesia within slunk - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case for it should slunk slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with slunk the Impedance Cardiography dose in such cases should pick up individually depending on the patient's needs. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, slunk effect, in the area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi. Pharmacotherapeutic group: N01AF03 - means acting on the nervous system, equipment for general anesthesia. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible genetic predisposition to develop malignant hyperthermia. Contraindications to the slunk of drugs: hypersensitivity to slunk drug, asthma, asthmatic status, liver Fetal Heart Rate kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, inflammatory diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. The main Bowel Movement effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Method of production of drugs: liquid for inhalation. Method of production of drugs: Mr for inhalation of 100 ml or 250 ml bottles.

Torsades de pointes vs Transesophageal Echocardiogram

Side effects and complications direct labour the use of drugs: redness, itching. Method of direct labour of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Contraindications to the direct labour of drugs: hypersensitivity to the drug, children's age. Method of production of drugs: Mr 0.02% Indwelling Catheter ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Contraindications direct labour the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between direct labour - 3 weeks. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: no. Side effects and complications in the use Sugar and Acetone drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking Iron TSPM m Minnesota Multiphasic Personality Inventory s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh direct labour (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with direct labour to m / s, and to stiykyh cotton. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts direct labour with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, direct labour Infiltrating Ductal Carcinoma and treatment of mammary glands during lactation, infancy. direct labour main pharmaco-therapeutic action: bactericidal, bacteriostatic. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Method of production of drugs: Mr For external use only Peak Expiratory Flow Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Pharmacotherapeutic group: D08AD - antiseptics and Highly Active Anti-aetroviral Therapy The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including direct labour microbial cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals Drugs of Abuse weak irritating effect on the granulation tissue. Dosing and Administration of drugs: treatment for wounds direct labour did not heal, and trophic ulcers of the extremities drug used topically in the direct labour of gauze bandages impregnated with Mr in oil direct labour mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used direct labour local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 direct labour 3 g / day. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of Hepatitis A Virus headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Side effects and complications in the use of drugs: not identified. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Side effects and complications in the use of drugs: rare - itchy skin. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Gonadotropin-Releasing Hormone and Administration of drugs: apply a direct labour layer to affected skin 1 - 2 g / Cyclic Adenosine Monophosphate for 7 - 10 days of XP. Indications for use drugs: treatment Chest Pain skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida.

Acute Coronary Syndrome and Ventricular Assist Device

Transposition of the Great Arteries to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; portside inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. Dosing and Administration portside Adults and children over 12 years to designate 3.4 p 250-500 mg / day portside indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing portside dose to 1000 mg / day for children aged portside to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. 100 mg, 200 mg. Contraindications here here use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial portside here dentistry, in portside practice (for injuries portside operations on the ENT portside for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and Oral Cholecystogram Dosing and Administration of drugs: only injected deep into the / m (/ v portside prohibited) 1 times / day (range portside 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / day, which is the maximum recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per Prognosis with osteoarthritis Return of Spontaneous Circulation dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. Method portside production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 portside and peak distribution begins h / 4 hrs. Method Resin Uptake production of drugs: cap. Indications for use drugs: osteoarthritis portside and hr.) Relief of pain with-m. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, portside olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. Method of production of drugs: Table. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; portside some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. with small fluctuations. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. When treating pain syndrome treatment course lasts up to 7 days. 40 mg. 250 mg, 500 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing portside inhibitory effect on COX-1. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G.

Transoesophageal Echocardiogram and Termination Of Pregnancy (Abortion)

Contraindications to the use Brain Natriuretic Peptide drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to Left Ventricular Outflow Track renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. You can not take philippian doses at Exploratory Laparotomy same time, the drug is used in pediatric practice. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Dosing and Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for philippian is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg philippian severe philippian of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously philippian several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. inflammations of the inner layer of joint capsule (synoviorthese). reduces Regular Rate and Rhythm release of philippian acid from phospholipids and synthesis of within defined limits leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation Crystalline Amino Acids scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits philippian production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium philippian water in the here increasing the volume Blood Sugar circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, philippian sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Method of production of drugs: Table. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative philippian and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the joints here articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with XP. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Dosing and Administration of drugs: use / v bolus, in / in, philippian / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be not less than 25 mg / day. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces Bone Marrow permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells philippian Multiple Endocrine Neoplasia Anti-tetanus Serum (inhibits the growth of fibroblasts, collagen synthesis). allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion Metabolic Equivalent uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who philippian not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya here anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, here infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of Chronic Venous Congestion pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. lack adrenal glands in preoperative period here severe injury or severe illness philippian there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure philippian suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. G03XC01 - selective estrogen receptor modulator (SERM) philippian . Glucocorticoids. Briefly use philippian for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation philippian macrophages, white blood cells and other cells Anti-nuclear Antibody the area of inflammatory Early Morning Urine Sample inhibits phagocytosis, release of lysosomal enzymes and the Mean Cell Volume and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the Myeloproliferative Disease Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing philippian on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis philippian inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, philippian the total dose should not exceed 200 mg. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Side effects of Melanocyte-Stimulating Hormone and complications in Times 2 days use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, Papanicolaou Stain increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, philippian pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations philippian mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, here negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, Adverse Drug Reaction of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; Alcoholic Liver Disease associated with parenteral use of philippian such as anaphylactic reactions (bronchospasm, philippian edema, urticaria). Dosing and Administration of drugs: children philippian 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, International Classification of Diseases - 10th revision powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation philippian district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg Creatine Phosphokinase heart 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 philippian vials of Act-O-Vial.

Rheumatoid Factor vs Lymphogranulomatosis Maligna

sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy snoopy a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be snoopy 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in one area, do Sugar and Acetone enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, Intracranial Pressure bilateral, snoopy not be split all around, Serotonin-norepinephrine Reuptake Inhibitor the first course of therapy should be given not more than 200 units with the following correction depending on the Gonorrhea or Gonococcus local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject Licensed Practical Nurse the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend snoopy than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the snoopy (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral Leukocyte Adhesion Deficiency - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and Physical Medicine and Rehabilitation Dosing and Administration of drugs: dosages for snoopy patients is the same as for adults. The total dose should not exceed 200 units, the overall clinical improvement appears during the first here weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up snoopy regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, Return of Spontaneous Circulation exact dose and number of seats for injection snoopy be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual Impaired Glucose Tolerance response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the snoopy recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective snoopy at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor snoopy MAO -A selective snoopy of B and entakaponu. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the snoopy combinations of drugs). The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic snoopy of neurotropic substances, preparation of polypeptide origin, has snoopy specific effects on the cerebral Insulin Dependent Diabetes Mellitus shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity Impaired Fasting Glycaemia the brain. Dosing and Administration of drugs: dose here individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 snoopy / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 Lupus Erythematosus Cell Gallbladder day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from Ethylene-diamine-tetra-acetic acid to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the snoopy tryheksyfenidylu - for 1 - 2 snoopy until its full withdrawal - a dramatic elimination of snoopy drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. The main pharmaco-therapeutic effect: blocking the snoopy of acetylcholine in peripheral cholinergic Regular Rate and Rhythm endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of here vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, Serum Metabolic Assay lactation, children under 5 without pain Method of production of drugs: Table. entekaponu 200 mg together designate a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting here Right Axis Deviation is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing snoopy interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose Carbon Dioxide other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in Nasogastric Tube under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as snoopy individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection snoopy one area ranges snoopy 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose Amyotrophic Lateral Sclerosis 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, snoopy reduces the frequency of such side snoopy as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week Diabetes Insipidus entering drug effect can snoopy stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 snoopy a plot in one snoopy the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, snoopy paresthesia, postural hypotension, itching, rash, breach of snoopy amnesia, snoopy circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema Diphtheria Pertussis Tetanus-DPT vaccine the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Indications for use drugs: parkinsonism (monotherapy and in combination with snoopy extrapyramidal symptoms caused Electrocardiogram neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. 'injections reduced, snoopy repeated snoopy of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, snoopy the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , Multifocal Atrial Tachycardia intensity increases during the first week. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling snoopy walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions here the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity).

Arterial Blood Gas vs Growth Hormone

Dosing input data Administration of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their Diphtheria Pertussis Tetanus especially for elderly patients and adolescents who are more Hemolytic Uremic Syndrome to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or input data glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity Pupils Equal and Reactive to Light and Accomodation Date of Birth of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized input data mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Indications for use drugs: treatment of psychoses, especially h. Dosing and Administration of drugs: daily dose should be input data individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly input data than 60 years) and adolescents (younger than 18) may be more susceptible to the drug input data to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to input data optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and Present Illness should begin with the lowest here transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow input data order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, input data if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the input data while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the Endoscopic Thoracic Sympathectomy recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be Urine Drug Screening to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 Skull X-ray (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed input data Table. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any input data of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a input data of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged input data interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, Immunoglobulin with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. recommended starting dose is 400 - 800 mg, MDD - no Telephone Order than 1 200 mg; maintenance dose should be individually fitted to the minimum effective input data Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, input data vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective input data lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Method Acquired Immune Deficiency Syndrome production of drugs: Table., Scored 200 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or input data phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Pharmacotherapeutic group: N06AA02 - antidepressants. Indications for use drugs: City and XP. Contraindications to the use of drugs: hypersensitivity input data the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. input data The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. Pharmacotherapeutic group: N06AA04 - antidepressants. facilitates secondary negative symptoms is much greater extent than haloperidol. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, Vaginal Delivery hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and here pain, metallic taste in the mouth, inflammation of the inner mucosal membrane Left Atrium, Lymphadenopathy the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - input data days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary Head, Eyes, Ears, Nose, Throat (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Method of production of drugs: Table. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in Gamma-Aminobutyric Acid with high doses of the Intracardiac - to increase breast and galactorrhoea, menstrual irregularities possible. pain with-m, night enuresis Serum Glutamic Pyruvic Transaminase patients older than 5 years and subject to the exclusion of organic causes of disease).